BIO-Europe EBD Group BIO BIO-Europe
Email this page Share this on LinkedIn Share this on Twitter

BIO-Europe® 2014 Press Releases

November 17, 201420th Annual BIO-Europe® 2014 partnering meetings outnumber all previous yearsSuccess of industry event confirms valued role of partnering in bringing drugs to patients
The 20th anniversary edition of BIO-Europe® international partnering conference wrapped up last week, November 3–5, in Frankfurt, Germany, at the Portalhaus Messe Frankfurt conference center. The conference attracted over 3,200 leading dealmakers from 54 countries comprising 1,786 companies made up of biotech, large and midsize pharma, and finance along with emerging com...  more ►

October 16, 2014BIO-Europe® 2014 Program is abundant showcase of life science pharma executives and thought leaders BIO-Europe® 2014 international partnering conference will take place, November 3–5 in Frankfurt, Germany, at the Portalhaus Messe Frankfurt conference center. BIO-Europe is Europe's largest partnering conference serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging...  more ►

October 8, 2014BIO-Europe® 2014 partnering meetings expected to surpass all previous events The BIO-Europe® 2014 international partnering conference will take place in one month on November 3–5 in Frankfurt, Germany, at the Portalhaus Messe Frankfurt. BIO-Europe is the largest dedicated partnering conference worldwide serving the life science industry. The 2014 Frankfurt event projects the number of one-to-one partnering meetings to surpass the 2013 all-time rec...  more ►

August 12, 2014BIO-Europe® 2014 kicks off its 20th year as life science partnering leader
Event will be held in Frankfurt, Germany this year
The twentieth annual BIO-Europe® international partnering conference will take place November 3–5 in Frankfurt, Germany, at the Portalhaus Messe Frankfurt conference center. "BIO-Europe has continued to be the leading European life science partnering event because of the high caliber companies that bring their teams to partner," said Florian Schoenhammer, Managing Direct...  more ►

August 1, 2014Spotlight on Frankfurt Business Facts The state of Hessen has top ranked cities: Frankfurt, Wiesbaden and Kassel are among the top 10 cities in Germany (based on WiWo City Ranking 2012). Frankfurt is Germany's major airport and leading hub in Europe with over 57.5 million passengers per year and 4,575 direct flight connections per week. Overall, 108 airlines fly to 295 destinations in 105 countries. There are tw...  more ►

partnering360® Blog

November 26, 2014 Objectives of translational medicine One of the hardest parts of translational medicine is melding the two objectives of the academic institution versus the Pharmaceutical company. In a recap of a session from BIO-Europe®, Insight looks at some of the differences between the two entities. Academic institutions looks at the scientific... more ►

November 25, 2014 A glimpse of exciting presenting companies at Biotech Showcase™ 2015 Biotech Showcase 2015 is coming up January 12–14, 2015 in San Francisco, and it’s already apparent that the list of presenting companies is full of innovative and inspiring companies. For example, Cortendo is a Swedish biotech with a pioneering approach in the field of  orphan drugs and... more ►

November 21, 2014 Become a BIO-Europe Spring® 2015 exhibitor and enhance your brand! BIO-Europe Spring will take place this March 9-11, 2015 in Paris, France.  This is a dynamic area to stand out and be noticed.  There will be over 2,100 leading life science executives and decision makers will congregate in the exhibit hall between partnering meetings. These are your customers: »... more ►

November 18, 2014 Part II: Do you have what it takes to win over investors? Tips from VCs on pitching your company taken from BIO-Europe® 2014 The following is Part II of some of the tips and takeaways on giving a “perfect pitch,”  taken from the “Perfect Pitch” workshop at BIO-Europe® 2014 in Frankfurt, Germany on November 3. Doug MacDougall, President of MacDougall Biomedical Communications, led the interactive workshop where... more ►

November 17, 2014 How do investors perceive value? Senior Industry leaders will share their perspectives at Biotech Showcase™ 2015 Biotech Showcase™ 2015 biotechnology investor and partnering conference will take place January 12–14, 2015 in San Francisco, CA at Parc 55 Wyndham San Francisco – Union Square.  The event brings executive-level delegates representing top public and private investment firms with the goal... more ►

partnering360:Insight Latest headlines from partnering360:Insight

November 11, 2014 Bayer committed to Open Innovation and Collaborators The Head of Global Drug Discovery at Bayer HealthCare and a Member of the Executive Committee, Andreas Busch described the strategy underlying partnering efforts that he said have delivered a very significant value to patients as well as to shareholders. more ►

November 11, 2014 Merck Serono embraces partnering in all its forms Executive VP and Head of Global Research and Development at Merck Serono, Luciano Rossetti is also a Member of the Executive Committee who joined the company in late July this year. He offered to share with the audience a perspective from what he called a brief tenure. more ►

November 11, 2014 European biotech poised for acceleration David Loew is Senior VP for Commercial Operations in Europe at Sanofi. Rather than focusing on the company, Loew turned the spotlight on a wider concern for promoting a stronger environment for biotechs and start-ups in Europe. more ►

November 11, 2014 Transformational deals that shaped the industry in 2014 Led by moderator David Stubbs, the Managing Director for Inverness Advisors, the goal for the panel was to provide insights for transformational deals of the past year. The session was led off by a truly transformational deal that saw the USD 14.2 billion divestiture by Merck of its consumer healthcare business to Bayer HealthCare in May, 2014. The deal makes Bayer the second-biggest over-the-counter drug maker behind Johnson & Johnson. more ►

November 11, 2014 Covagen and vasopharm: Driving the right deal from the sell side A partner with the law firm Dentons, Peter Homberg teased out insights from the executives of two biotechs who are on the leading edge of negotiations with large pharma companies, providing first-hand accounts of their experiences. more ►

Arrow Up

See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2014 EBD GmbH
Privacy Policy
Terms of Use
BIO-Europe EBD Group BIO BIO-Europe